Methodology to Incorporate the BED and EUD in Patient-Specific 3-Dimensional Dosimetry for Non-Hodgkin’s Lymphoma Patients Targeted with 131I Tositumomab Therapy
Byline
HÂ Amro1 *, SÂ Wilderman2 , YÂ Dewaraja3 , PÂ Roberson4 , (1)Â Radiation Oncology, University of Michigan, Ann Arbor, MI, (2)Â Nuclear Engeneering, University of Michigan ,Ann Arbor, MI, (3)Â Radiology, University of Michigan, Ann Arbor, MI, (4)Â Univ Michigan, Ann Arbor, MI